Factors influencing prescribing the first add-on disease-modifying antirheumatic drugs in patients initiating methotrexate for rheumatoid arthritis

• Main Authors: Yinan Huang (Author), Satabdi Chatterjee (Author), Sandeep K. Agarwal (Author), Hua Chen (Author), Michael L. Johnson (Author), Rajender R. Aparasu (Author)
• 格式: 圖書
• 出版: Elsevier, 2023-09-01T00:00:00Z.
• 主題: article
• 在線閱讀: Connect to this object online.

Background: Advances in Disease-Modifying Antirheumatic Drugs (DMARDs) have expanded the treatment landscape for Rheumatoid Arthritis (RA). Guidelines recommend adding either conventional synthetic (cs), biologic (b), or targeted synthetic (ts) DMARDs to methotrexate (MTX) for managing RA. Limited e...